Given that MAPK1 has been shown to be a miR-28-5p target in myeloproliferative neoplasm [36], it is possible that miR-28-5p regulates SREBF2 both directly and indirectly through MAPK. The gene discussed is MAPK1; the disease is myeloproliferative neoplasm.